Misplaced Pages

Mario Deng: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 01:44, 12 July 2019 editMariodeng (talk | contribs)24 editsNo edit summary← Previous edit Revision as of 00:25, 26 August 2019 edit undoZanhe (talk | contribs)Autopatrolled, Extended confirmed users, Pending changes reviewers132,020 edits fix infobox, etcNext edit →
Line 16: Line 16:


is a German-Chinese cardiologist specialized in the care of patients with advanced heart failure. Deng is a Professor of Medicine in the David Geffen School of Medicine at the ]. is a German-Chinese cardiologist specialized in the care of patients with advanced heart failure. Deng is a Professor of Medicine in the David Geffen School of Medicine at the ].
{{Infobox person {{Infobox scientist
|name = Mario Chih-Hsiung Karl Deng |name = Mario Chih-Hsiung Karl Deng
] |image = Mario-Deng.jpg
⚫ |nationality = German, American
<small>Professor of Medicine</small>
⚫ |education =University of Hamburg <br> Free University of Berlin <br> Stanford University

|field =Cardiology
⚫ |awards =
}} }}


⚫ == Biography ==
{| class=infobox width=270px
|colspan=2 align=center|
|-
⚫ |'''Nationality''' ||German, American
|-
⚫ |'''Education''' ||University of Hamburg <br> Free University of Berlin <br> Stanford University
|-
|'''Profession''' ||Cardiologist
|-
|'''Field''' ||Heart Failure, Mechanical Support, Heart Transplant
|-
|'''Research''' ||Interaction between cardiovascular and immune system <br> Relational Medicine <br>
|-
⚫ |'''Awards''' ||
|}

⚫ == <big>Biography</big> ==
Deng was born in West Berlin as a single child to a Chinese forestry scientist and a German lawyer <ref>https://www.welt.de/wissenschaft/article707363/Professor-Mario-Deng-Bypaesse-fuer-Bill-Clinton.html?wtrid=onsite.onsitesearch</ref>. In 1992-1993, he spent time as a post-doctoral fellow at ] for training in advanced heart failure, transplantation cardiology and molecular cardiology <ref>http://med.stanford.edu/cvmedicine/education/advanced-fellowships/ahfc/prior-fellows.html </ref>. From 1992 to 2000, Deng became a professor at ], building the Interdisciplinary Heart Failure and Heart Transplant Program<ref>{{Cite journal |pmid = 7558467|year = 1995|last1 = Deng|first1 = M. C.|title = The Interdisciplinary Heart Failure and Transplant Program Münster: A 5-year experience|journal = International Journal of Cardiology|volume = 50|issue = 1|pages = 7–17|last2 = Breithardt|first2 = G.|last3 = Scheld|first3 = H. H.|doi = 10.1016/0167-5273(95)02344-V}}</ref> of Muenster University. In 2000, Deng joined ] as the Director of Cardiac Transplantation Research.<ref>https://www.aerzteblatt.de/archiv/25222/Universitaeten</ref> In 2001, Deng was appointed the founding Medical Director of the Mechanical Circulatory Support Database <ref>https://www.jhltonline.org/article/S1053-2498(05)00491-2/abstract</ref> of the International Society for Heart and Lung Transplantation. In 2011, he was recruited to the University of California, Los Angeles to re-build the Heart Transplant Program as Director of the Advanced Heart Failure, Mechanical Circulatory Support, and Heart Transplant Program <ref> https://www.uclahealth.org/u-magazine/dr-mario-c-deng</ref> Deng was born in West Berlin as a single child to a Chinese forestry scientist and a German lawyer <ref>https://www.welt.de/wissenschaft/article707363/Professor-Mario-Deng-Bypaesse-fuer-Bill-Clinton.html?wtrid=onsite.onsitesearch</ref>. In 1992-1993, he spent time as a post-doctoral fellow at ] for training in advanced heart failure, transplantation cardiology and molecular cardiology <ref>http://med.stanford.edu/cvmedicine/education/advanced-fellowships/ahfc/prior-fellows.html </ref>. From 1992 to 2000, Deng became a professor at ], building the Interdisciplinary Heart Failure and Heart Transplant Program<ref>{{Cite journal |pmid = 7558467|year = 1995|last1 = Deng|first1 = M. C.|title = The Interdisciplinary Heart Failure and Transplant Program Münster: A 5-year experience|journal = International Journal of Cardiology|volume = 50|issue = 1|pages = 7–17|last2 = Breithardt|first2 = G.|last3 = Scheld|first3 = H. H.|doi = 10.1016/0167-5273(95)02344-V}}</ref> of Muenster University. In 2000, Deng joined ] as the Director of Cardiac Transplantation Research.<ref>https://www.aerzteblatt.de/archiv/25222/Universitaeten</ref> In 2001, Deng was appointed the founding Medical Director of the Mechanical Circulatory Support Database <ref>https://www.jhltonline.org/article/S1053-2498(05)00491-2/abstract</ref> of the International Society for Heart and Lung Transplantation. In 2011, he was recruited to the University of California, Los Angeles to re-build the Heart Transplant Program as Director of the Advanced Heart Failure, Mechanical Circulatory Support, and Heart Transplant Program <ref> https://www.uclahealth.org/u-magazine/dr-mario-c-deng</ref>


== <big>Career</big> == == Career ==
=== Multidisciplinary care and clinical outcomes in advanced heart failure === === Multidisciplinary care and clinical outcomes in advanced heart failure ===
Deng was responsible for the conduct and publication of the Comparative Outcomes and Clinical Profiles in Transplantation (COCPIT Study)<ref>{{Cite journal |pmid = 10968814|pmc = 27468|year = 2000|last1 = Deng|first1 = M. C.|title = Effect of receiving a heart transplant: Analysis of a national cohort entered on to a waiting list, stratified by heart failure severity. Comparative Outcome and Clinical Profiles in Transplantation (COCPIT) Study Group|journal = BMJ (Clinical Research Ed.)|volume = 321|issue = 7260|pages = 540–5|last2 = De Meester|first2 = J. M.|last3 = Smits|first3 = J. M.|last4 = Heinecke|first4 = J.|last5 = Scheld|first5 = H. H.|doi = 10.1136/bmj.321.7260.540}}</ref> which contributed to the discussion about reorganization of the heart allocation rules in Europe and the United States <ref>http://news.bbc.co.uk/2/hi/health/904627.stm</ref>. Deng was responsible for the conduct and publication of the Comparative Outcomes and Clinical Profiles in Transplantation (COCPIT Study)<ref>{{Cite journal |pmid = 10968814|pmc = 27468|year = 2000|last1 = Deng|first1 = M. C.|title = Effect of receiving a heart transplant: Analysis of a national cohort entered on to a waiting list, stratified by heart failure severity. Comparative Outcome and Clinical Profiles in Transplantation (COCPIT) Study Group|journal = BMJ (Clinical Research Ed.)|volume = 321|issue = 7260|pages = 540–5|last2 = De Meester|first2 = J. M.|last3 = Smits|first3 = J. M.|last4 = Heinecke|first4 = J.|last5 = Scheld|first5 = H. H.|doi = 10.1136/bmj.321.7260.540}}</ref> which contributed to the discussion about reorganization of the heart allocation rules in Europe and the United States <ref>http://news.bbc.co.uk/2/hi/health/904627.stm</ref>.
Line 49: Line 35:
=== Development of a blood test to detect cardiac rejection === === Development of a blood test to detect cardiac rejection ===
Deng co-developed the first in history diagnostic and prognostic peripheral blood mononuclear cell gene expression profiling biomarker test<ref>{{Cite journal |doi = 10.1111/j.1600-6143.2005.01175.x|pmid = 16433769|title = Noninvasive Discrimination of Rejection in Cardiac Allograft Recipients Using Gene Expression Profiling|journal = American Journal of Transplantation|volume = 6|issue = 1|pages = 150–160|year = 2006|last1 = Deng|first1 = M. C.|last2 = Eisen|first2 = H. J.|last3 = Mehra|first3 = M. R.|last4 = Billingham|first4 = M.|last5 = Marboe|first5 = C. C.|last6 = Berry|first6 = G.|last7 = Kobashigawa|first7 = J.|last8 = Johnson|first8 = F. L.|last9 = Starling|first9 = R. C.|last10 = Murali|first10 = S.|last11 = Pauly|first11 = D. F.|last12 = Baron|first12 = H.|last13 = Wohlgemuth|first13 = J. G.|last14 = Woodward|first14 = R. N.|last15 = Klingler|first15 = T. M.|last16 = Walther|first16 = D.|last17 = Lal|first17 = P. G.|last18 = Rosenberg|first18 = S.|last19 = Hunt|first19 = S.}}</ref> in heart transplantation medicine that gained US-FDA-regulatory clearance <ref>https://www.accessdata.fda.gov/cdrh_docs/reviews/k073482.pdf</ref>and international evidence-based medicine guideline acceptance <ref>https://www.allomap.com/wp-content/uploads/2015/12/Guidelines.pdf</ref> to rule out rejection without invasive biopsies <ref>https://consumer.healthday.com/cardiovascular-health-information-20/heart-attack-news-357/genetic-test-can-detect-heart-transplant-rejection-529826.html</ref> <ref>https://www.nyp.org/pdf/nypnewsletter_heart_fall2006.pdf</ref> <ref>https://www.cuimc.columbia.edu/news/accuracy-gene-expression-test-heart-transplant-patients-confirmed-independent-clinical-data</ref> <ref>http://newsroom.ucla.edu/portal/ucla/blood-test-can-be-used-to-predict-250080.aspx</ref> Deng co-developed the first in history diagnostic and prognostic peripheral blood mononuclear cell gene expression profiling biomarker test<ref>{{Cite journal |doi = 10.1111/j.1600-6143.2005.01175.x|pmid = 16433769|title = Noninvasive Discrimination of Rejection in Cardiac Allograft Recipients Using Gene Expression Profiling|journal = American Journal of Transplantation|volume = 6|issue = 1|pages = 150–160|year = 2006|last1 = Deng|first1 = M. C.|last2 = Eisen|first2 = H. J.|last3 = Mehra|first3 = M. R.|last4 = Billingham|first4 = M.|last5 = Marboe|first5 = C. C.|last6 = Berry|first6 = G.|last7 = Kobashigawa|first7 = J.|last8 = Johnson|first8 = F. L.|last9 = Starling|first9 = R. C.|last10 = Murali|first10 = S.|last11 = Pauly|first11 = D. F.|last12 = Baron|first12 = H.|last13 = Wohlgemuth|first13 = J. G.|last14 = Woodward|first14 = R. N.|last15 = Klingler|first15 = T. M.|last16 = Walther|first16 = D.|last17 = Lal|first17 = P. G.|last18 = Rosenberg|first18 = S.|last19 = Hunt|first19 = S.}}</ref> in heart transplantation medicine that gained US-FDA-regulatory clearance <ref>https://www.accessdata.fda.gov/cdrh_docs/reviews/k073482.pdf</ref>and international evidence-based medicine guideline acceptance <ref>https://www.allomap.com/wp-content/uploads/2015/12/Guidelines.pdf</ref> to rule out rejection without invasive biopsies <ref>https://consumer.healthday.com/cardiovascular-health-information-20/heart-attack-news-357/genetic-test-can-detect-heart-transplant-rejection-529826.html</ref> <ref>https://www.nyp.org/pdf/nypnewsletter_heart_fall2006.pdf</ref> <ref>https://www.cuimc.columbia.edu/news/accuracy-gene-expression-test-heart-transplant-patients-confirmed-independent-clinical-data</ref> <ref>http://newsroom.ucla.edu/portal/ucla/blood-test-can-be-used-to-predict-250080.aspx</ref>

<br>
=== Development of a blood test to predict survival in heart failure === === Development of a blood test to predict survival in heart failure ===
Since 2005, the Deng lab started to develop a genomic blood test to better predict outcomes in patients with various forms of advanced heart failure<ref>{{Cite journal |doi = 10.1371/journal.pone.0189420|pmid = 29236770|pmc = 5728510|title = Association between preoperative peripheral blood mononuclear cell gene expression profiles, early postoperative organ function recovery potential and long-term survival in advanced heart failure patients undergoing mechanical circulatory support|journal = PLOS ONE|volume = 12|issue = 12|pages = e0189420|year = 2017|last1 = Bondar|first1 = Galyna|last2 = Togashi|first2 = Ryan|last3 = Cadeiras|first3 = Martin|last4 = Schaenman|first4 = Joanna|last5 = Cheng|first5 = Richard K.|last6 = Masukawa|first6 = Lindsay|last7 = Hai|first7 = Josephine|last8 = Bao|first8 = Tra-Mi|last9 = Chu|first9 = Desai|last10 = Chang|first10 = Eleanor|last11 = Bakir|first11 = Maral|last12 = Kupiec-Weglinski|first12 = Sophie|last13 = Groysberg|first13 = Victoria|last14 = Grogan|first14 = Tristan|last15 = Meltzer|first15 = Joseph|last16 = Kwon|first16 = Murray|last17 = Rossetti|first17 = Maura|last18 = Elashoff|first18 = David|last19 = Reed|first19 = Elaine|last20 = Ping|first20 = Pei Pei|last21 = Deng|first21 = Mario C.|bibcode = 2017PLoSO..1289420B}}</ref> <ref>http://newsroom.ucla.edu/releases/genomic-blood-test-predicts-surgical-outcomes-in-advanced-heart-failure-patients</ref> <ref>https://mariodenglab.dgsom.ucla.edu/pages/</ref>. Since 2005, the Deng lab started to develop a genomic blood test to better predict outcomes in patients with various forms of advanced heart failure<ref>{{Cite journal |doi = 10.1371/journal.pone.0189420|pmid = 29236770|pmc = 5728510|title = Association between preoperative peripheral blood mononuclear cell gene expression profiles, early postoperative organ function recovery potential and long-term survival in advanced heart failure patients undergoing mechanical circulatory support|journal = PLOS ONE|volume = 12|issue = 12|pages = e0189420|year = 2017|last1 = Bondar|first1 = Galyna|last2 = Togashi|first2 = Ryan|last3 = Cadeiras|first3 = Martin|last4 = Schaenman|first4 = Joanna|last5 = Cheng|first5 = Richard K.|last6 = Masukawa|first6 = Lindsay|last7 = Hai|first7 = Josephine|last8 = Bao|first8 = Tra-Mi|last9 = Chu|first9 = Desai|last10 = Chang|first10 = Eleanor|last11 = Bakir|first11 = Maral|last12 = Kupiec-Weglinski|first12 = Sophie|last13 = Groysberg|first13 = Victoria|last14 = Grogan|first14 = Tristan|last15 = Meltzer|first15 = Joseph|last16 = Kwon|first16 = Murray|last17 = Rossetti|first17 = Maura|last18 = Elashoff|first18 = David|last19 = Reed|first19 = Elaine|last20 = Ping|first20 = Pei Pei|last21 = Deng|first21 = Mario C.|bibcode = 2017PLoSO..1289420B}}</ref> <ref>http://newsroom.ucla.edu/releases/genomic-blood-test-predicts-surgical-outcomes-in-advanced-heart-failure-patients</ref> <ref>https://mariodenglab.dgsom.ucla.edu/pages/</ref>.
Line 57: Line 43:
The creation of a framework to personalize high–tech modern medicine encounters is reflected in Deng’s research collaboration with Professor ( and David Geffen School of Medicine) in the "Relational Medicine" project <ref>http://www.relationalmedicinefoundation.org/</ref> <ref>http://ampersand.gseis.ucla.edu/federica-raia-book-on-relational-medicine-reveals-doctor-patient-collaboration-2/</ref> <ref>https://connect.uclahealth.org/2018/10/17/former-bruin-football-player-tackles-life-following-heart-transplant/</ref>. Deng is Co-Founder and Co-President of the Relational Medicine Foundation. The creation of a framework to personalize high–tech modern medicine encounters is reflected in Deng’s research collaboration with Professor ( and David Geffen School of Medicine) in the "Relational Medicine" project <ref>http://www.relationalmedicinefoundation.org/</ref> <ref>http://ampersand.gseis.ucla.edu/federica-raia-book-on-relational-medicine-reveals-doctor-patient-collaboration-2/</ref> <ref>https://connect.uclahealth.org/2018/10/17/former-bruin-football-player-tackles-life-following-heart-transplant/</ref>. Deng is Co-Founder and Co-President of the Relational Medicine Foundation.


==<big>Selected Publications</big>== ==Selected Publications==
* Deng MC, De Meester JMJ, Smits JMA, Heinecke J, Scheld HH, on behalf of COCPIT Study Group. The impact of heart failure severity on outcome in cardiac transplant candidates. Br Med J 2000;321:540-545. PMCID: PMC4133547. * Deng MC, De Meester JMJ, Smits JMA, Heinecke J, Scheld HH, on behalf of COCPIT Study Group. The impact of heart failure severity on outcome in cardiac transplant candidates. Br Med J 2000;321:540-545. PMCID: PMC4133547.


Line 70: Line 56:
*Raia F, Deng MC. Relational Medicine – Personalizing Modern Healthcare: The Practice of High-Tech Medicine As A RelationalAct. World Scientific Publishing/Imperial College Press, London/Singapore 2014 Deng 2014C *Raia F, Deng MC. Relational Medicine – Personalizing Modern Healthcare: The Practice of High-Tech Medicine As A RelationalAct. World Scientific Publishing/Imperial College Press, London/Singapore 2014 Deng 2014C


==<big>References</big>== ==References==
{{reflist}}

== Mario Deng ==


{{AFC submission|||ts=20190704021119|u=Mariodeng|ns=118}} {{AFC submission|||ts=20190704021119|u=Mariodeng|ns=118}}

Revision as of 00:25, 26 August 2019

This article, Mario Deng, has recently been created via the Articles for creation process. Please check to see if the reviewer has accidentally left this template after accepting the draft and take appropriate action as necessary.
Reviewer tools: Inform author
  • Comment: He is certainly notable, butthis is a promotional autobiography, not a neutrally worded encyclopedia article.First step is removing all adjectives of praise of excellence or importance. You can not claim "pioneer" or "internationally recognized" without an exact quotation from an unquestionably reliable 3rd party source, such as national level awards.For his publications, we list the 5 or so mostcited, using data from Google Scholar or ISI. In this connection, please note that there is difficulty dealing with the multiple authors in multi-center trials--they count only for the leader of the study or principal author, if that can be determined.For other references , see WP:REFBEGIN for the format. DGG ( talk ) 07:55, 29 June 2019 (UTC)


This article, Mario Deng, has recently been created via the Articles for creation process. Please check to see if the reviewer has accidentally left this template after accepting the draft and take appropriate action as necessary.
Reviewer tools: Inform author

Mario Chih-Hsiung Karl Deng is a German-Chinese cardiologist specialized in the care of patients with advanced heart failure. Deng is a Professor of Medicine in the David Geffen School of Medicine at the University of California, Los Angeles.

Mario Chih-Hsiung Karl Deng
File:Mario-Deng.jpg
NationalityGerman, American
EducationUniversity of Hamburg
Free University of Berlin
Stanford University
AwardsForbes 27 Top Cardiologists
Scientific career
FieldsCardiology

Biography

Deng was born in West Berlin as a single child to a Chinese forestry scientist and a German lawyer . In 1992-1993, he spent time as a post-doctoral fellow at Stanford University for training in advanced heart failure, transplantation cardiology and molecular cardiology . From 1992 to 2000, Deng became a professor at Muenster University, building the Interdisciplinary Heart Failure and Heart Transplant Program of Muenster University. In 2000, Deng joined Columbia University as the Director of Cardiac Transplantation Research. In 2001, Deng was appointed the founding Medical Director of the Mechanical Circulatory Support Database of the International Society for Heart and Lung Transplantation. In 2011, he was recruited to the University of California, Los Angeles to re-build the Heart Transplant Program as Director of the Advanced Heart Failure, Mechanical Circulatory Support, and Heart Transplant Program

Career

Multidisciplinary care and clinical outcomes in advanced heart failure

Deng was responsible for the conduct and publication of the Comparative Outcomes and Clinical Profiles in Transplantation (COCPIT Study) which contributed to the discussion about reorganization of the heart allocation rules in Europe and the United States .

Development of a blood test to detect cardiac rejection

Deng co-developed the first in history diagnostic and prognostic peripheral blood mononuclear cell gene expression profiling biomarker test in heart transplantation medicine that gained US-FDA-regulatory clearance and international evidence-based medicine guideline acceptance to rule out rejection without invasive biopsies

Development of a blood test to predict survival in heart failure

Since 2005, the Deng lab started to develop a genomic blood test to better predict outcomes in patients with various forms of advanced heart failure .

Development of a humanistic framework in high-tech medicine

The creation of a framework to personalize high–tech modern medicine encounters is reflected in Deng’s research collaboration with Professor Federica Raia (UCLA Graduate School of Education and Information Studies and David Geffen School of Medicine) in the "Relational Medicine" project . Deng is Co-Founder and Co-President of the Relational Medicine Foundation.

Selected Publications

  • Deng MC, De Meester JMJ, Smits JMA, Heinecke J, Scheld HH, on behalf of COCPIT Study Group. The impact of heart failure severity on outcome in cardiac transplant candidates. Br Med J 2000;321:540-545. PMCID: PMC4133547.
  • Deng MC, Edwards LB, Taylor DO, Hertz MI, Rowe AW, Keck B, Kormos RL, Naftel D, Kirklin J. Mechanical circulatory support device database of the international society for heart and lung transplantation: third annual report-2005. J Heart Lung Transplant 2005;24:1182-1187. PMID: 16143231
  • Deng MC, Eisen HJ, Mehra RM, Billingham M, Marboe CC, Berry G, Kobashigawa J, Johnson FL, Starling RC, Murali S, Pauly DF, Baron H, Wohlgemuth JG, Woodward RN, Klingler TM, Walther D, Lal PG, Rosenberg S, Hunt SA, for the CARGO Investigators. Non-invasive detection of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 2006;6:150-160. PMID: 23602870.
  • Deng MC, Elashoff B, Pham MX, Teuteberg JJ, Kfoury AG, Starling RC, Cappola TP, Kao A, Anderson AS, Cotts WG, Ewald GA, Baran DA, Bogaev RC, Shahzad K, Hiller D, Yee J, Valantine HA; for the IMAGE Study Group. Utility of Gene Expression Profiling Score Variability to Predict Clinical Events in Heart Transplant Recipients. Transplantation. 2014 Jan 31. PMID: 24492465
  • Bondar G, Togashi R, Cadeiras M, Schaenman J, Cheng RK, Masukawa L, Hai J, Bao TM, Chu D, Chang E, Bakir M, Kupiec-Weglinski S, Groysberg V, Grogan T, Meltzer J, Kwon M, Rossetti M, Elashoff D, Reed E, Ping PP, Deng MC. Association between preoperative peripheral blood mononuclear cell gene expression profiles, early postoperative organ function recovery potential and long-term survival in advanced heart failure patients undergoing mechanical circulatory support. PLoS One. 2017 Dec 13;12(12). PMCID: PMC5728510.
  • Raia F, Deng MC. Relational Medicine – Personalizing Modern Healthcare: The Practice of High-Tech Medicine As A RelationalAct. World Scientific Publishing/Imperial College Press, London/Singapore 2014 Deng 2014C

References

  1. https://www.welt.de/wissenschaft/article707363/Professor-Mario-Deng-Bypaesse-fuer-Bill-Clinton.html?wtrid=onsite.onsitesearch
  2. http://med.stanford.edu/cvmedicine/education/advanced-fellowships/ahfc/prior-fellows.html
  3. Deng, M. C.; Breithardt, G.; Scheld, H. H. (1995). "The Interdisciplinary Heart Failure and Transplant Program Münster: A 5-year experience". International Journal of Cardiology. 50 (1): 7–17. doi:10.1016/0167-5273(95)02344-V. PMID 7558467.
  4. https://www.aerzteblatt.de/archiv/25222/Universitaeten
  5. https://www.jhltonline.org/article/S1053-2498(05)00491-2/abstract
  6. https://www.uclahealth.org/u-magazine/dr-mario-c-deng
  7. Deng, M. C.; De Meester, J. M.; Smits, J. M.; Heinecke, J.; Scheld, H. H. (2000). "Effect of receiving a heart transplant: Analysis of a national cohort entered on to a waiting list, stratified by heart failure severity. Comparative Outcome and Clinical Profiles in Transplantation (COCPIT) Study Group". BMJ (Clinical Research Ed.). 321 (7260): 540–5. doi:10.1136/bmj.321.7260.540. PMC 27468. PMID 10968814.
  8. http://news.bbc.co.uk/2/hi/health/904627.stm
  9. Deng, M. C.; Eisen, H. J.; Mehra, M. R.; Billingham, M.; Marboe, C. C.; Berry, G.; Kobashigawa, J.; Johnson, F. L.; Starling, R. C.; Murali, S.; Pauly, D. F.; Baron, H.; Wohlgemuth, J. G.; Woodward, R. N.; Klingler, T. M.; Walther, D.; Lal, P. G.; Rosenberg, S.; Hunt, S. (2006). "Noninvasive Discrimination of Rejection in Cardiac Allograft Recipients Using Gene Expression Profiling". American Journal of Transplantation. 6 (1): 150–160. doi:10.1111/j.1600-6143.2005.01175.x. PMID 16433769.
  10. https://www.accessdata.fda.gov/cdrh_docs/reviews/k073482.pdf
  11. https://www.allomap.com/wp-content/uploads/2015/12/Guidelines.pdf
  12. https://consumer.healthday.com/cardiovascular-health-information-20/heart-attack-news-357/genetic-test-can-detect-heart-transplant-rejection-529826.html
  13. https://www.nyp.org/pdf/nypnewsletter_heart_fall2006.pdf
  14. https://www.cuimc.columbia.edu/news/accuracy-gene-expression-test-heart-transplant-patients-confirmed-independent-clinical-data
  15. http://newsroom.ucla.edu/portal/ucla/blood-test-can-be-used-to-predict-250080.aspx
  16. Bondar, Galyna; Togashi, Ryan; Cadeiras, Martin; Schaenman, Joanna; Cheng, Richard K.; Masukawa, Lindsay; Hai, Josephine; Bao, Tra-Mi; Chu, Desai; Chang, Eleanor; Bakir, Maral; Kupiec-Weglinski, Sophie; Groysberg, Victoria; Grogan, Tristan; Meltzer, Joseph; Kwon, Murray; Rossetti, Maura; Elashoff, David; Reed, Elaine; Ping, Pei Pei; Deng, Mario C. (2017). "Association between preoperative peripheral blood mononuclear cell gene expression profiles, early postoperative organ function recovery potential and long-term survival in advanced heart failure patients undergoing mechanical circulatory support". PLOS ONE. 12 (12): e0189420. Bibcode:2017PLoSO..1289420B. doi:10.1371/journal.pone.0189420. PMC 5728510. PMID 29236770.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  17. http://newsroom.ucla.edu/releases/genomic-blood-test-predicts-surgical-outcomes-in-advanced-heart-failure-patients
  18. https://mariodenglab.dgsom.ucla.edu/pages/
  19. http://www.relationalmedicinefoundation.org/
  20. http://ampersand.gseis.ucla.edu/federica-raia-book-on-relational-medicine-reveals-doctor-patient-collaboration-2/
  21. https://connect.uclahealth.org/2018/10/17/former-bruin-football-player-tackles-life-following-heart-transplant/
This article, Mario Deng, has recently been created via the Articles for creation process. Please check to see if the reviewer has accidentally left this template after accepting the draft and take appropriate action as necessary.
Reviewer tools: Inform author
Categories: